Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid
Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid
Not yet recruiting · NCT07210554 · Registry updated 2025-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid | Skin and Connective Tissue Diseases, autoimmune disease, bullous pemphigoid, immune system disorder, skin disorder, vesiculobullous skin disease | Not yet recruiting | Phase 3 | 2025-10-07 | NCT07210554 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chengdu Kangnuoxing Biopharma,Inc. | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University First Hospital | Beijing | China | 41 |